AI assistant
Sending…
IMPACT BIOMEDICAL INC. — Director's Dealing 2024
Sep 17, 2024
35295_dirs_2024-09-16_fd89c655-ead8-4a69-bce6-606ddfd293fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IMPACT BIOMEDICAL INC. (IBO)
CIK: 0001834105
Period of Report: 2024-09-16
Reporting Person: Sims Melissa Kaye (Director)
More from IMPACT BIOMEDICAL INC.
Regulatory Filings
2026
Apr 22
Capital/Financing Update
2026
Apr 6
Director's Dealing
2026
Mar 26
M&A Activity
2026
Mar 4
Director's Dealing
2026
Jan 6
Proxy Solicitation & Information Statement
2025
Dec 30
Proxy Solicitation & Information Statement
2025
Dec 11
Interim / Quarterly Report
2025
Nov 7
Declaration of Voting Results & Voting Rights Announcements
2025
Nov 6
Capital/Financing Update
2025
Oct 27